Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.
The Trump administration first instituted a ban ending all human fetal tissue research at NIH in 2019, but it was reversed by ...